Prognosis
Delays Hit Oxford-Astra Vaccine Production for U.K. Supply
- England’s doctors on alert in case vaccine ready by Christmas
- But production of AstraZeneca-Oxford doses is behind schedule
Despite supply limitations, health officials in England said doctors across the country are being put on stand by to administer vaccines just in case shots are approved for use before the end of this year.
Photographer: Kirsty Wigglesworth/AP Photos
This article is for subscribers only.
The U.K. is struggling to stock up on supplies of a potentially game-changing coronavirus vaccine, a top government official has said.
Kate Bingham, chair of the U.K. Vaccine Taskforce, said only 4 million doses of the Oxford-AstraZeneca Plc shot will be available by the end of the year, far fewer than the 30 million that were due to be ready by September.